Survival benefit of lung transplantation for chronic obstructive pulmonary disease in sweden.

Hanan Tanash; Gerdt C Riise; Magnus Ekström; Lennart Hansson; Eeva Piitulainen

doi:10.1016/j.athoracsur.2014.07.030

Survival benefit of lung transplantation for chronic obstructive pulmonary disease in sweden.

Hanan Tanash, Gerdt C Riise, Magnus Ekström, Lennart Hansson, Eeva Piitulainen

Research output: Contribution to journal › Article › peer-review

Abstract

Lung transplantation (LTx) is a therapeutic option for patients with life-threatening chronic obstructive pulmonary disease (COPD) that is refractory to conventional therapies. The survival benefit of LTx for COPD is difficult to assess. The aim of this study was to evaluate the Swedish series of LTx performed to treat COPD and to identify differences in outcome between COPD related to severe alpha-1-antitrypsin deficiency (AATD) and COPD with normal alpha-1-antitrypsin (AAT) levels.

Original language	English
Pages (from-to)	1930-1935
Journal	Annals of Thoracic Surgery
Volume	98
Issue number	6
DOIs	https://doi.org/10.1016/j.athoracsur.2014.07.030
Publication status	Published - 2014

Subject classification (UKÄ)

Respiratory Medicine and Allergy

Access to Document

10.1016/j.athoracsur.2014.07.030

http://www.ncbi.nlm.nih.gov/pubmed/25443001?dopt=Abstract

Cite this

@article{0c0d9b5786c449a8b358fd3214ecb196,

title = "Survival benefit of lung transplantation for chronic obstructive pulmonary disease in sweden.",

abstract = "Lung transplantation (LTx) is a therapeutic option for patients with life-threatening chronic obstructive pulmonary disease (COPD) that is refractory to conventional therapies. The survival benefit of LTx for COPD is difficult to assess. The aim of this study was to evaluate the Swedish series of LTx performed to treat COPD and to identify differences in outcome between COPD related to severe alpha-1-antitrypsin deficiency (AATD) and COPD with normal alpha-1-antitrypsin (AAT) levels.",

author = "Hanan Tanash and Riise, {Gerdt C} and Magnus Ekstr{\"o}m and Lennart Hansson and Eeva Piitulainen",

year = "2014",

doi = "10.1016/j.athoracsur.2014.07.030",

language = "English",

volume = "98",

pages = "1930--1935",

journal = "Annals of Thoracic Surgery",

issn = "1552-6259",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Survival benefit of lung transplantation for chronic obstructive pulmonary disease in sweden.

AU - Tanash, Hanan

AU - Riise, Gerdt C

AU - Ekström, Magnus

AU - Hansson, Lennart

AU - Piitulainen, Eeva

PY - 2014

Y1 - 2014

N2 - Lung transplantation (LTx) is a therapeutic option for patients with life-threatening chronic obstructive pulmonary disease (COPD) that is refractory to conventional therapies. The survival benefit of LTx for COPD is difficult to assess. The aim of this study was to evaluate the Swedish series of LTx performed to treat COPD and to identify differences in outcome between COPD related to severe alpha-1-antitrypsin deficiency (AATD) and COPD with normal alpha-1-antitrypsin (AAT) levels.

AB - Lung transplantation (LTx) is a therapeutic option for patients with life-threatening chronic obstructive pulmonary disease (COPD) that is refractory to conventional therapies. The survival benefit of LTx for COPD is difficult to assess. The aim of this study was to evaluate the Swedish series of LTx performed to treat COPD and to identify differences in outcome between COPD related to severe alpha-1-antitrypsin deficiency (AATD) and COPD with normal alpha-1-antitrypsin (AAT) levels.

U2 - 10.1016/j.athoracsur.2014.07.030

DO - 10.1016/j.athoracsur.2014.07.030

M3 - Article

C2 - 25443001

SN - 1552-6259

VL - 98

SP - 1930

EP - 1935

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

IS - 6

ER -

Survival benefit of lung transplantation for chronic obstructive pulmonary disease in sweden.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this